Lucas Morin is a doctoral student at the Aging Research Center (ARC), a division from the Department of Neurobiology, Care Sciences and Society at Karolinska Institutet. His research is mostly focused on pharmacoepidemiology and end-of-life care.
Before joining the Aging Research Center, Lucas was the Director of the French National Observatory on End-of-Life Care in Paris, France.
Areas of research
- Use of potentially inadequate medical interventions at the end of life
- Impact of spousal bereavement in old age
- Quality of end-of-life care in nursing homes
- Polyphamarcy and inappropriate drug use among older people
Thesis (2015-2019): "Drug prescribing in older people at the end of life"
- Supervisor: Prof Kristina Johnell
- Co-supervisors: Prof Johan Fastbom, Prof Marie-Laure Laroche
Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
Eur. J. Clin. Pharmacol. 2018 Oct;74(10):1333-1342
The epidemiology of polypharmacy in older adults: register-based prospective cohort study.
Clin Epidemiol 2018 ;10():289-298
Hospital end-of-life care in haematological malignancies.
BMJ Support Palliat Care 2018 Sep;8(3):314-324
Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
Am. J. Med. 2017 08;130(8):927-936.e9
Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study.
Eur. J. Cancer 2017 07;79():31-40
Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Drugs Aging 2017 07;34(7):529-533
Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
J Am Med Dir Assoc 2017 Jun;18(6):551.e1-551.e7
Use of chemotherapy near the end of life: what factors matter?
Ann. Oncol. 2017 04;28(4):809-817
Estimating the need for palliative care at the population level: A cross-national study in 12 countries.
Palliat Med 2017 06;31(6):526-536
Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review.
J Am Med Dir Assoc 2016 09;17(9):862.e1-9
Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.
J Am Geriatr Soc 2016 09;64(9):1851-7
End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study.
Br. J. Dermatol. 2016 Sep;175(3):583-92
Discussing end-of-life issues in nursing homes: a nationwide study in France.
Age Ageing 2016 05;45(3):395-402
Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries.
J Epidemiol Community Health 2016 Jan;70(1):17-24
A population-level study of place of death and associated factors in Sweden.
Scand J Public Health 2015 Nov;43(7):744-51
Place of death of people living with Parkinson's disease: a population-level study in 11 countries.
BMC Palliat Care 2015 May;14():28
Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates.
Br J Clin Pharmacol 2015 Aug;80(2):315-24
Variation in the place of death among nursing home residents in France.
Age Ageing 2015 May;44(3):415-21
International variation in place of death of older people who died from dementia in 14 European and non-European countries.
J Am Med Dir Assoc 2015 Feb;16(2):165-71
Other scientific activities
- Co-chair of the “Big data in End-of-Life Care Research” task force of the European Association for Palliative Care (EAPC)
- Member of the Scientific Committee for the 2019 Annual Congress of the European Association for Palliative Care
- Member of the Scientific Committee for the 2019 Annual Congress of the French Association for Palliative Care (SFAP)
- Member of the “Geriatric Pharmacoepidemiology” special interest group of the International Society for Pharmacoepidemiology (ISPE)